A hormone that reflects ovarian egg reserve and fertility timeline.
Anti-Mullerian hormone, or AMH, is made by the small developing follicles in a woman's ovaries. The level reflects the pool of eggs still in reserve, known as ovarian reserve. Men make AMH in the testes, where it has a different role.
In women, AMH is a widely used marker of ovarian reserve. It stays fairly steady across the cycle, so it can be measured on any day, and it helps predict how the ovaries may respond to fertility treatment.
AMH falls with age and approaches very low levels near menopause. A high AMH is common in polycystic ovary syndrome. AMH indicates egg quantity, not egg quality, and on its own it does not confirm or rule out the chance of conceiving naturally.
Aniva reads your result against research-backed ranges, not just the lab's wide normal. The reference shown below is specific to this biomarker.
Strongly age dependent in women, declining over time. Guidance only and assay dependent. Ranges vary by lab.
| Group | Typical range |
|---|---|
| Women, reproductive age | ~1.0 to 6.8 ug/L (about 7 to 49 pmol/L) |
| Women, low reserve | below ~1.0 ug/L |
| Women, near menopause | very low to undetectable |
Source: LOINC 38476-8. Always use age specific ranges. Confirm against your own laboratory's range.
Your result, read against your age, gives a sense of your ovarian reserve. It supports planning around fertility and family timing and helps anticipate the response to treatments like IVF.
Hormonal contraception can modestly lower AMH. Results differ between assays, so values are not directly comparable across labs. AMH reflects egg quantity, not quality, and does not predict natural conception on its own.
Best read together with FSH, estradiol, and, on ultrasound, the antral follicle count, alongside your age.
One annual membership, 100+ biomarkers, every result explained in plain language with a personalized action plan and concierge guidance.
